Norbert W. Bischofberger - 15 Nov 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
President & CEO, Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
15 Nov 2023
Net transactions value
+$1,470,395
Form type
4
Filing time
17 Nov 2023, 17:41:27 UTC
Previous filing
02 Jun 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Purchase $1,102,718 +1,370,688 +169% $0.8045 2,180,297 15 Nov 2023 Direct F1
transaction KRON Common Stock Purchase $261,514 +262,433 +12% $0.9965 2,442,730 16 Nov 2023 Direct F2
transaction KRON Common Stock Purchase $106,162 +97,935 +4% $1.08 2,540,665 17 Nov 2023 Direct F3
holding KRON Common Stock 4,370,494 15 Nov 2023 See footnote F4
holding KRON Common Stock 263,750 15 Nov 2023 See footnote F5
holding KRON Common Stock 263,750 15 Nov 2023 See footnote F6
holding KRON Common Stock 263,750 15 Nov 2023 See footnote F7
holding KRON Common Stock 263,750 15 Nov 2023 See footnote F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $0.8045, and the range of prices were between $0.765 and $0.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 The weighted average purchase price for the transaction reported was $0.9965, and the range of prices were between $0.90 and $1.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F3 The weighted average purchase price for the transaction reported was $1.084, and the range of prices were between $1.04 and $1.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F4 By the Norbert W. & Inger A. Bischofberger Revocable Inter Vivos Trust, dtd August 29, 1994.
F5 By the Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Exempt Trust dated April 29, 2020.
F6 By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The David Michael Anthony Dynasty GST Non-Exempt Trust dated April 29, 2020
F7 By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Exempt Trust dated April 29, 2020.
F8 By Norbert W. Bischofberger and Inger A. Bischofberger, Trustees of The Irene Alisha Bischofberger Dynasty GST Non-Exempt Trust dated April 29, 2020